| Date | Title | Description |
| 26.03.2021 | Chime Biologics Announced the Completion of $190 Million Ser... | March 26, 2021, Wuhan - Chime Biologics, a China-based, world-class CDMO company, announced today th... |
| 08.04.2020 | Chime Biologics Has Signed a Contract with Wuhan East Lake H... | WUHAN, Apr. 8, 2020 — Chime Biologics, formerly “Xikang (Wuhan) biopharmaceutical Co., Ltd.”, today ... |
| 10.03.2020 | Chime Biologics Is Evolving into One of the Leading CDMOs in... | Wuhan, China, March 10, 2020 – Chime Biologics, a China-based, world-class Contract Development and ... |
| 26.02.2020 | JHL Biotech Focuses on CDMO and Biologics Development for Gl... | HSINCHU, Taiwan, February 26, 2020 — With a globally-focused enthusiasm and aspiration to build sust... |
| 13.01.2020 | CredSimple Acquires Glenridge Health to Build the Industry's... | Strategic acquisition will streamline services, control costs, and ensure compliance
NEW YORK, Jan.... |
| 16.08.2019 | JHL Focusing on New Biosimilar Pipeline and Global Expansion... | HSINCHU, Taiwan and WUHAN, China, August 16, 2019 — JHL Biotech has reached a settlement agreement w... |
| 01.04.2019 | FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin | RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) - ADMA Biologics, Inc. (NASDAQ: A... |
| 06.10.2018 | Strand Life Sciences Acquires India Diagnostics Business Fro... | October 6, 2018 | Bangalore
Strand Life Sciences announced an agreement to acquire the India medica... |
| 26.07.2018 | ADMA Biologics Reports Successful Close-Out of Its April 201... | RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:AD... |
| 18.06.2018 | Quest Analytics Acquires BetterDoctor | [Appleton, WI] – [June 18, 2018] – Quest Analytics, the leading provider of network access and adequ... |
| 22.01.2018 | Celgene Corporation to Acquire Juno Therapeutics |
SUMMIT, N.J. & SEATTLE--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) and Juno Therapeut... |
| 21.12.2017 | JHL Biotech Submits Clinical Trial Application in Europe for... | HSINCHU, Taiwan and WUHAN, China, December 21, 2017 - JHL Biotech Inc. (Stock Code: 6540.TWO) announ... |
| 18.12.2017 | JHL Submits Clinical Trial Application for Proposed Bevacizu... | JHL Biotech, at December 15, 2017, has submitted a Phase I Clinical Trial Application (“CTA”) to Eur... |
| 06.06.2017 | ADMA Biologics Completes Acquisition of Biotest's Therapy Bu... | Transaction Creates Vertically Integrated Commercial Plasma Products Company
Combined Entity has Mu... |
| 05.04.2017 | China FDA Accepts JHL’s First Clinical Trial Application | Wuhan, China and Hsinchu, Taiwan - JHL Biotech Inc. (Stock Code: 6540.TWO) is announcing that its Cl... |
| 29.03.2017 | JHL Doses First Patient In JHL1101 Phase I European Trial | JHL Biotech Inc. (Stock Code: 6540.TWO) today announced that the first patient has been dosed in the... |
| 10.01.2017 | HyperMed Imaging, Inc. Receives FDA Clearance for Its New Hy... | HyperMed Imaging, Inc. announced today that it has received clearance from the U.S. Food and Drug Ad... |
| 05.12.2016 | Sanofi and JHL Biotech Announce Strategic Biologics Alliance... | Shanghai, China - 5 December 2016 – Sanofi (EURONEXT: SAN and NYSE: SNY), a global healthcare leader... |
| 27.07.2016 | Scientific Publication by a Group Including Juno Therapeutic... | by John Carroll
July 26, 2016
CAR-Ts won’t be on the market before next year, but the technology ar... |
| 25.02.2016 | JHL Biotech Announces Mechanical Completion of its Wuhan Bio... | Wuhan, China and Amersham, UK; 25 February 2016: JHL Biotech (TWEM: 6540) and GE Healthcare’s Life S... |
| 27.01.2016 | Venaxis Announces Transaction with Strand Life Sciences | CASTLE ROCK, Colo., January 26, 2016 /PRNewswire/ - Venaxis®, Inc. (Nasdaq: APPY), announced today t... |
| 03.11.2015 | JHL Biotech Intends to Manufacture Biosimilars in Its New Fa... | JHL Biotech intends to manufacture biosimilars in its new facility
November 3, 2015 | By Eric Palme... |
| 05.10.2015 | Strand Life Sciences Is Featured in GenomeWeb Article | Oct 05, 2015
Monica Heger
NEW YORK (GenomeWeb) – Strand Life Sciences is aiming to position its 15... |
| 02.10.2015 | JHL Biotech Lists on the Taiwan Emerging Stock Board | HSINCHU, TAIWAN – October 2, 2015—JHL Biotech (TWEM: 6540), an emerging biosimilars company incorpor... |
| 21.09.2015 | FDA Accepts ADMA Biologics License Application for RI-002 | RAMSEY, N.J., Sept. 21, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage bi... |
| 13.05.2015 | JHL Biotech Successfully Raises $45.6 Million Series C Finan... | HSINCHU, TAIWAN – May 11, 2015 – JHL Biotech, Inc., an emerging biopharmaceutical company, today ann... |
| 18.12.2014 | Juno Therapeutics Announces Pricing of Initial Public Offeri... | December 18, 2014 06:14 PM Eastern Standard Time
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. ... |
| 05.12.2014 | Opus Bio to License CD22 CAR T Cell Technology to Juno | GREENWICH, CT (December 5, 2014) - Opus Bio, Inc., today announced that Juno Therapeutics, Inc. has ... |
| 03.12.2014 | ADMA Biologics Announces Positive Top-Line Phase III Data fo... | RAMSEY, N.J., Dec. 3, 2014 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biop... |
| 05.11.2014 | ADMA Biologics Approved for Trading on NASDAQ | RAMSEY, N.J., Nov. 5, 2014 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage bioph... |
| 27.08.2014 | Alcon to Acquire WaveTec® Vision, Developer of First Commerc... | Fort Worth, Texas, Aug. 27, 2014 - Alcon, the global leader in eye care and the second largest divis... |
| 14.08.2014 | Lentigen Corporation Announces Sale of Lentiviral Vector Man... |
Greenwich, Connecticut, USA, August 14, 2014 -- Lentigen Corporation, a global leader in lentivira... |
| 09.05.2014 | Launch of The Strand Triesta Center for Cancer Genomics | - |
| 08.05.2014 | HCG Announces New Standard-of-Care for Cancer Treatment in I... | - |
| 17.12.2013 | Curie-Cancer and Strand Launch Curie Image Database | PARIS and SAN FRANCISCO, December 17, 2013 /PRNewswire/ --
A breakthrough image management platform... |
| 05.12.2013 | Strand Life Sciences to Partner with US Based El Camino Hosp... | BANGALORE, India, December 5, 2013 /PRNewswire/ --
Strand Life Sciences Private Limited, a global l... |
| 18.11.2013 | Why Strand Life Sciences Wants Doctors to Genetically Profil... | Seema Singh | Forbes India
Updated:March 7, 2013, 5:50 PM IST
We've all heard tragic stories about... |
| 18.11.2013 | Strand launches Early Access Program for Clinical Genomics I... | - |
| 22.10.2013 | BetterDoctor Raises $2.6 Million to Alleviate the Pain of Fi... | CHRISTINA FARR OCTOBER 22, 2013 1:12 PM
BetterDoctor has raised $2.6 million in funding to do exact... |
| 17.10.2013 | ADMA Biologics Announces Pricing of Initial Public Offering | RAMSEY, N.J.--ADMA Biologics, Inc. (OTCQB: ADMA), a late-stage biopharmaceutical company that develo... |
| 25.09.2013 | GE Healthcare Life Sciences to Build KUBio Modular Biopharma... | New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia
Cha... |
| 24.09.2013 | Pancreatic Cancer Imaging Agent Earns MabVax $1.75 Million S... | MabVax Therapeutics has received a contract from the National Cancer Institute under the Small Busin... |
| 06.09.2013 | WhiteGlove Health Names New Chief Executive Officer | AUSTIN, Texas--(BUSINESS WIRE)--WhiteGlove Health, (WGH) a leading service driven and outcomes-orien... |
| 13.05.2013 | JHL Biotech Partners With GE Healthcare Life Sciences to Bui... | On March 13, 2013, leaders from JHL Biotech and GE Healthcare Life Sciences signed a strategic coope... |
| 12.03.2013 | Cordis Acquires Flexible Stenting Solutions, a Biomark Capit... | Agreement Expands Treatment Options for Advanced Peripheral Artery Disease
Bridgewater, NJ – March ... |
| 13.02.2013 | Lentigen Receives U.S. Orphan Drug Designation For Novel Gen... | GAITHERSBURG, Md., Feb. 13, 2013 /PRNewswire/ -- Lentigen Corporation, a biotechnology company speci... |
| 11.02.2013 | Strand Life Sciences raises Series B Round | BANGALORE, February 11, 2013 /PRNewswire/ --
Genomics Towards Precision Medicine
Today, Strand Lif... |
| 21.11.2012 | MabVax Therapeutics Secures First Series B Tranche | 11/21/2012 - 1:29PM
Clinical stage biotechnology company MabVax Therapeutics has closed the first t... |
| 14.11.2011 | Lentigen and UH Case Medical Center Initiate Phase I Trial U... | CLEVELAND - University Hospitals (UH) Case Medical Center, Case Western Reserve University School of... |